Ping la

Ping La is an experienced professional in the field of molecular biology, currently serving as Associate Director at Tevard Biosciences since March 2023, focusing on process development and improvement in collaboration with contract development and manufacturing organizations (CDMOs). Previously, Ping La held the position of Senior Manager on Process Development Upstream at Editas Medicine from April 2021 to January 2023, where responsibilities included providing subject matter expertise in AAV upstream process development and managing contract research organizations (CROs). As a Senior Scientist at WuXi Advanced Therapies from March 2020 to April 2021, Ping La contributed to the production scale-up of products for clinical trials. Earlier experience includes a significant tenure as a Scientist at the Children's Hospital of Philadelphia from January 2007 to March 2020 and as a Postdoctoral Fellow at the University of Pennsylvania's Abramson Cancer Center from 2000 to 2006. Ping La earned a Ph.D. in Molecular Biology from the Chinese Academy of Sciences from 1996 to 2000.